At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,630 enrolled
Drug / intervention
Bone Marrow Aspirationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bone Marrow Analysis In Early-Stage Breast Cancer
In Brief
A clinical study evaluating Bone Marrow Aspiration for Breast Cancer. Completed, enrolled 1,630 participants across 53 sites in 2 countries.
Detailed Summary
RATIONALE: Diagnostic procedures that detect tumor cells in the bone marrow may help doctors predict disease recurrence and plan more effective treatment. PURPOSE: This clinical trial is studying how well diagnostic procedures work in detecting tumor cells in the bone marrow of patients who have undergone surgery for stage I, stage II, or stage IIIA breast cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesCanada, United States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 2004
Enrollment StartJan 2007
Primary CompletionJul 2018
Study CompletionAug 2018
TodayJul 2026
First PostedAug 5, 2004
Enrollment StartJan 1, 2007
Primary CompletionJul 1, 2018
Study CompletionAug 1, 2018
TodayJul 1, 2026
Enrollment to primary: 11.5 yearsPosted 21.9 years ago
Interventions
Bone Marrow Aspirationprocedure